MYBPC3 and myocardial infarction: Cardiac myosin-binding protein C (cMyBP-C), plasminogen, complement C8 beta, coagulation factor II, and alpha-1-acid glycoprotein have all demonstrated significant elevations in cases of acute myocardial infarction, thereby indicating the involvement of myocardial injury, inflammation, and coagulation pathways, with cMyBP-C positioning itself as a robust emerging biomarker for its cardiac specificity and sensitivity [75,76,77,78].